1,2-dimethylhydrazine increases expression ISO Atp6v1b2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of ATP6V1B2 mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO Atp6v1b2 (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO Atp6v1b2 (Mus musculus) 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 17alpha-ethynylestradiol affects expression ISO Atp6v1b2 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of ATP6V1B2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of ATP6V1B2 protein CTD PMID:12297525 17beta-estradiol increases expression ISO Atp6v1b2 (Mus musculus) 6480464 Estradiol results in increased expression of ATP6V1B2 mRNA CTD PMID:15289156 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of ATP6V1B2 mRNA CTD PMID:26496021 2,2,2-tetramine decreases expression EXP 6480464 Trientine results in decreased expression of ATP6V1B2 protein CTD PMID:19634143 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Atp6v1b2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ATP6V1B2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP6V1B2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP6V1B2 mRNA CTD PMID:23152189 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19954255 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of ATP6V1B2 mRNA CTD PMID:21346803 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 2-amino-14 and 16-dimethyloctadecan-3-ol results in decreased expression of ATP6V1B2 protein CTD PMID:32044396 3,4-methylenedioxymethamphetamine increases expression ISO Atp6v1b2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of ATP6V1B2 mRNA CTD PMID:20188158 and PMID:26251327 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ATP6V1B2 mRNA CTD PMID:28522335 3-chloropropane-1,2-diol multiple interactions ISO ATP6V1B2 (Homo sapiens) 6480464 ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of ATP6V1B2 mRNA] CTD PMID:34812491 3-chloropropane-1,2-diol decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 alpha-Chlorohydrin results in decreased expression of ATP6V1B2 mRNA and alpha-Chlorohydrin results in decreased expression of ATP6V1B2 protein CTD PMID:27732882 more ... 4,4'-sulfonyldiphenol affects expression ISO ATP6V1B2 (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone affects the expression of ATP6V1B2 protein CTD PMID:31945527 4,4'-sulfonyldiphenol increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ATP6V1B2 protein CTD PMID:34186270 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ATP6V1B2 mRNA CTD PMID:36041667 acrolein multiple interactions ISO ATP6V1B2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATP6V1B2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATP6V1B2 mRNA CTD PMID:32699268 aflatoxin B1 increases expression ISO Atp6v1b2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of ATP6V1B2 mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of ATP6V1B2 mRNA CTD PMID:27153756 all-trans-retinoic acid increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Tretinoin results in increased expression of ATP6V1B2 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO ATP6V1B2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATP6V1B2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATP6V1B2 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ATP6V1B2 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of ATP6V1B2 mRNA CTD PMID:30779732 antimycin A decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Antimycin A results in decreased expression of ATP6V1B2 mRNA CTD PMID:33512557 antirheumatic drug decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of ATP6V1B2 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of ATP6V1B2 mRNA CTD PMID:33212167 azoxystrobin decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 azoxystrobin results in decreased expression of ATP6V1B2 mRNA CTD PMID:33512557 benzatropine decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Benztropine results in decreased expression of ATP6V1B2 protein CTD PMID:34122009 benzene increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Benzene results in increased expression of ATP6V1B2 mRNA CTD PMID:19162166 benzo[a]pyrene affects methylation ISO ATP6V1B2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of ATP6V1B2 promoter CTD PMID:27901495 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ATP6V1B2 mRNA and [bisphenol A co-treated with Estradiol] results in increased expression of ATP6V1B2 mRNA CTD PMID:26496021 and PMID:36041667 bisphenol A decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of ATP6V1B2 protein CTD PMID:34186270 bisphenol A increases expression ISO Atp6v1b2 (Mus musculus) 6480464 bisphenol A results in increased expression of ATP6V1B2 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP6V1B2 mRNA CTD PMID:34947998 bisphenol A increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 bisphenol A results in increased expression of ATP6V1B2 mRNA CTD PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ATP6V1B2 mRNA CTD PMID:25181051 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ATP6V1B2 mRNA CTD PMID:36041667 bisphenol F increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 bisphenol F results in increased expression of ATP6V1B2 protein CTD PMID:34186270 cadmium atom multiple interactions ISO ATP6V1B2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V1B2 mRNA CTD PMID:35301059 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of ATP6V1B2 promoter CTD PMID:22457795 cadmium dichloride multiple interactions ISO ATP6V1B2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V1B2 mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO Atp6v1b2 (Mus musculus) 6480464 Cadmium Chloride results in increased expression of ATP6V1B2 mRNA CTD PMID:30030080 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ATP6V1B2 mRNA CTD PMID:33453195 caffeine multiple interactions ISO Atp6v1b2 (Mus musculus) 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of ATP6V1B2 mRNA CTD PMID:17293106 carbon nanotube affects expression ISO Atp6v1b2 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of ATP6V1B2 protein CTD PMID:21135415 carbon nanotube increases expression ISO Atp6v1b2 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of ATP6V1B2 mRNA CTD PMID:25554681 carbon nanotube affects expression EXP 6480464 Nanotubes and Carbon affects the expression of ATP6V1B2 mRNA CTD PMID:19836432 chloropicrin increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 chloropicrin results in increased expression of ATP6V1B2 mRNA CTD PMID:26352163 chlorpromazine decreases expression EXP 6480464 Chlorpromazine results in decreased expression of ATP6V1B2 protein CTD PMID:19441803 chlorpyrifos increases expression ISO Atp6v1b2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of ATP6V1B2 mRNA CTD PMID:37019170 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of ATP6V1B2 protein CTD PMID:34058248 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of ATP6V1B2 protein CTD PMID:19441803 clozapine decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Clozapine results in decreased expression of ATP6V1B2 protein CTD PMID:34122009 cobalt dichloride increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of ATP6V1B2 mRNA CTD PMID:19320972 copper atom increases expression EXP 6480464 Copper results in increased expression of ATP6V1B2 mRNA CTD PMID:22465980 copper(0) increases expression EXP 6480464 Copper results in increased expression of ATP6V1B2 mRNA CTD PMID:22465980 CU-O LINKAGE increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 cupric oxide results in increased expression of ATP6V1B2 mRNA CTD PMID:22077320 deguelin decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 deguelin results in decreased expression of ATP6V1B2 mRNA CTD PMID:33512557 deoxynivalenol decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 deoxynivalenol results in decreased expression of ATP6V1B2 protein CTD PMID:33890134 diethylstilbestrol increases expression ISO Atp6v1b2 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of ATP6V1B2 mRNA CTD PMID:15289156 diethylstilbestrol multiple interactions EXP 6480464 Testosterone inhibits the reaction [Diethylstilbestrol results in decreased expression of ATP6V1B2 protein] CTD PMID:12297525 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of ATP6V1B2 protein CTD PMID:12297525 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of ATP6V1B2 mRNA CTD PMID:29391264 ethanol affects splicing ISO Atp6v1b2 (Mus musculus) 6480464 Ethanol affects the splicing of ATP6V1B2 mRNA CTD PMID:30319688 ethanol increases expression ISO Atp6v1b2 (Mus musculus) 6480464 Ethanol results in increased expression of ATP6V1B2 mRNA CTD PMID:30319688 fenpyroximate decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 fenpyroximate results in decreased expression of ATP6V1B2 mRNA CTD PMID:33512557 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of ATP6V1B2 protein CTD PMID:12297525 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ATP6V1B2 mRNA CTD PMID:24136188 folic acid decreases expression ISO Atp6v1b2 (Mus musculus) 6480464 Folic Acid results in decreased expression of ATP6V1B2 mRNA CTD PMID:25629700 genistein increases expression ISO Atp6v1b2 (Mus musculus) 6480464 Genistein results in increased expression of ATP6V1B2 mRNA CTD PMID:15289156 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ATP6V1B2 mRNA CTD PMID:22061828 and PMID:33387578 ginsenoside Rb1 multiple interactions ISO ATP6V1B2 (Homo sapiens) 6480464 ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of ATP6V1B2 mRNA] CTD PMID:34812491 haloperidol decreases expression ISO Atp6v1b2 (Mus musculus) 6480464 Haloperidol results in decreased expression of ATP6V1B2 mRNA CTD PMID:16465460 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of ATP6V1B2 mRNA CTD PMID:36868495 ivermectin decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of ATP6V1B2 protein CTD PMID:32959892 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of ATP6V1B2 mRNA CTD PMID:11578147 lead diacetate increases expression ISO Atp6v1b2 (Mus musculus) 6480464 lead acetate results in increased expression of ATP6V1B2 mRNA CTD PMID:25270620 leflunomide decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 leflunomide results in decreased expression of ATP6V1B2 mRNA CTD PMID:28988120 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of ATP6V1B2 protein CTD PMID:19826936 methamphetamine decreases expression ISO Atp6v1b2 (Mus musculus) 6480464 Methamphetamine results in decreased expression of ATP6V1B2 protein CTD PMID:16181420 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of ATP6V1B2 mRNA CTD PMID:16393664 Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of ATP6V1B2 mRNA CTD PMID:28349193 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of ATP6V1B2 protein CTD PMID:22430071 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of ATP6V1B2 mRNA CTD PMID:24136188 nickel atom decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Nickel results in decreased expression of ATP6V1B2 mRNA CTD PMID:23195993 ozone multiple interactions ISO ATP6V1B2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATP6V1B2 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO Atp6v1b2 (Mus musculus) 6480464 Acetaminophen affects the expression of ATP6V1B2 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ATP6V1B2 mRNA CTD PMID:33387578 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of ATP6V1B2 mRNA CTD PMID:19162173 phenylpropanolamine decreases expression ISO Atp6v1b2 (Mus musculus) 6480464 Phenylpropanolamine results in decreased expression of ATP6V1B2 mRNA CTD PMID:16465460 picoxystrobin decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of ATP6V1B2 mRNA CTD PMID:33512557 quartz affects expression EXP 6480464 Quartz affects the expression of ATP6V1B2 mRNA CTD PMID:19836432 resveratrol multiple interactions ISO ATP6V1B2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP6V1B2 mRNA CTD PMID:23557933 rotenone increases oxidation EXP 6480464 Rotenone results in increased oxidation of ATP6V1B2 protein CTD PMID:30951809 rotenone decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Rotenone results in decreased expression of ATP6V1B2 mRNA CTD PMID:33512557 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ATP6V1B2 protein CTD PMID:29459688 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of ATP6V1B2 protein CTD PMID:26141394 tebufenpyrad decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of ATP6V1B2 mRNA CTD PMID:33512557 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Diethylstilbestrol results in decreased expression of ATP6V1B2 protein] CTD PMID:12297525 tetrachloromethane increases expression ISO Atp6v1b2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of ATP6V1B2 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ATP6V1B2 mRNA CTD PMID:34492290 trichostatin A affects expression ISO ATP6V1B2 (Homo sapiens) 6480464 trichostatin A affects the expression of ATP6V1B2 mRNA CTD PMID:28542535 valproic acid increases expression ISO ATP6V1B2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ATP6V1B2 mRNA CTD PMID:23179753 and PMID:29154799 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ATP6V1B2 mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ATP6V1B2 mRNA CTD PMID:23034163 zinc dichloride decreases expression ISO ATP6V1B2 (Homo sapiens) 6480464 zinc chloride results in decreased expression of ATP6V1B2 mRNA CTD PMID:18947441